Immuneering Corp - Ordinary Shares Class A
IMRX
Get informed when a big investor buys or sells
+ FollowMarket Cap$163.72M
Close$
$2.84
45.5% downside
Current Fair Value
45.5% downsideOvervalued by 45.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $163.72 Million |
|---|---|
| Enterprise Value | $126.03 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.27 |
| Beta | 0.37 |
| Outstanding Shares | 64,697,219 |
Return
| Return on Equity | -14918.40% |
|---|---|
| Return on Assets | -14082.59% |
| Return on Invested Capital | -15639.36% |
Valuation & Multiples
| P/E Ratio | -4.34 |
|---|---|
| PEG | -22.07 |
| Price to Sales | - |
| Price to Book Ratio | 2.6 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$-0.26
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$-0.31
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 165.61% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 22.92%▼ 43.66% |
|---|---|
| Total Invested | $50.33M▼ 67.38% |
| Investors Holding | 39▼ 62.00% |
ESG Score
No data
About Immuneering Corp
2,021 employees